The company is looking for an exceptional scientist to lead discovery research with special emphasis on understanding gene therapy for renal diseases.
Ninevah Therapeutics (NTX) is a discovery company developing gene therapies for kidney orphan diseases. Our lead program is an AAV-based therapy for genetic nephrotic syndrome (NTX014). NTX mission is to translate NTX014 from discovery to a first-in-human trial (Phase 2a).
A postdoctoral position is available for a highly motivated and creative scientist interested to be part of this just launched biotech company. The successful candidate will join an entrepreneurial team and will collaborate with top researchers and advisors.
The ideal candidate should enjoy building an early-stage biotech company, partnering with academic institutions and open to embrace a wide variety of projects out of the lab.
This position starts in March 2020 and it is based in Barcelona.
- PhD in Biomedical/Cell and Molecular Biology or related fields.
- Research experience in Renal Biology highly preferred.
- Recommended research experience includes protein biochemistry, disease model generation, cellular assay development, genomics and/or cell imaging systems.
- Demonstrated ability to be highly productive in a fluid, fast-paced and teamwork environment.